Media coverage about China Biologic Products (NASDAQ:CBPO) has trended positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. China Biologic Products earned a news sentiment score of 0.25 on Accern’s scale. Accern also gave headlines about the biopharmaceutical company an impact score of 47.2389252314295 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

These are some of the headlines that may have impacted Accern’s scoring:

Several equities research analysts have recently commented on CBPO shares. BidaskClub downgraded shares of China Biologic Products from a “sell” rating to a “strong sell” rating in a research note on Saturday, August 5th. Jefferies Group LLC restated a “buy” rating on shares of China Biologic Products in a research note on Friday, August 4th. Finally, Zacks Investment Research upgraded shares of China Biologic Products from a “sell” rating to a “hold” rating in a research note on Wednesday, November 15th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the company’s stock. China Biologic Products has an average rating of “Hold” and a consensus price target of $137.50.

Shares of China Biologic Products (CBPO) traded up $0.15 during trading hours on Tuesday, hitting $85.09. 116,275 shares of the stock traded hands, compared to its average volume of 244,390. China Biologic Products has a 52 week low of $72.21 and a 52 week high of $122.19. The firm has a market cap of $2,380.00, a P/E ratio of 19.17, a PEG ratio of 1.41 and a beta of 1.71.

TRADEMARK VIOLATION NOTICE: This story was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at

About China Biologic Products

Insider Buying and Selling by Quarter for China Biologic Products (NASDAQ:CBPO)

Receive News & Stock Ratings for China Biologic Products Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Biologic Products Inc. and related stocks with our FREE daily email newsletter.